Top Markets
Coin of the day
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.

Inhibitor Therapeutics, Inc.

INTI
Classificação em ações #30838
Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida,... Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida, is a pharmaceutical development enterprise. The company is dedicated to inventing and commercializing medical treatments for patients in the United States who suffer from various cancerous and non-cancerous cell proliferation conditions. A primary focus of their work involves advancing SUBA-Itraconazole, an oral variant of the drug itraconazole, for therapeutic applications in prostate and lung cancers. Furthermore, Inhibitor Therapeutics, Inc. has successfully completed a positive Phase 2b clinical trial for SUBA-Itraconazole in the management of basal cell carcinoma nevus syndrome. The organization was previously known as HedgePath Pharmaceuticals, Inc. until its name was officially changed in August 2019.
Preço da ação
$0.089
Última sincronização: 2026-08-17
Valor de mercado
$15.36M
Variação (1 dia)
50.59%
Variação (1 ano)
111.85%
País
US
Negociar Inhibitor Therapeutics, Inc. (INTI)

Categoria

Preço INTI com a capitalização de mercado de B
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.
INTI
$0.089
Capitalização de mercado de Inhibitor Therapeutics, Inc.(INTI)
Valor de mercado: $15.36M
Em August 2026, Inhibitor Therapeutics, Inc. tem uma capitalização de mercado de $15.36M. Isso faz com que Inhibitor Therapeutics, Inc. seja a 30838th empresa mais valiosa do mundo em termos de capitalização de mercado, de acordo com os nossos dados. A capitalização de mercado, também chamada de market cap, é o valor total de mercado das ações em circulação de uma empresa de capital aberto e é amplamente utilizada para medir o valor de uma empresa.
Histórico de capitalização de mercado de Inhibitor Therapeutics, Inc. de 2003 a 2026
INTI comparado com o topo de 5 mais populares stocks
Preço para INTI Ativo B Capitalização de mercado de B Resultados
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.
$30,749.66 $15.36M
$5.307T +34,550,085.07%
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.
$26,369.80 $15.36M
$4.551T +29,628,891.27%
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.
$24,072.99 $15.36M
$4.154T +27,048,208.47%
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.
$20,794.30 $15.36M
$3.589T +23,364,277.97%
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.
$16,206.69 $15.36M
$2.797T +18,209,663.87%